4D Molecular Therapeutics (NASDAQ:FDMT) Announces Quarterly Earnings Results, Beats Estimates By $0.07 EPS
4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) released its earnings results on Tuesday. The company reported ($0.66) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.73) by $0.07, Zacks reports. The firm had revenue of $0.03 million during the quarter, compared to analyst estimates of $1.44 million. 4D Molecular Therapeutics had […]
More Stories
Alliancebernstein L.P. Has $5.12 Million Holdings in Roku, Inc. (NASDAQ:ROKU)
Alliancebernstein L.P. trimmed its stake in shares of Roku, Inc. (NASDAQ:ROKU – Free Report) by 2.3% during the fourth quarter,...
Fmr LLC Buys 687,675 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Fmr LLC increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 91.6% in the fourth quarter,...
Reliance, Inc. (NYSE:RS) Position Boosted by Fmr LLC
Fmr LLC boosted its holdings in Reliance, Inc. (NYSE:RS – Free Report) by 25.1% during the 4th quarter, Holdings Channel...
JetBlue Airways Co. (NASDAQ:JBLU) Shares Acquired by Fmr LLC
Fmr LLC boosted its stake in JetBlue Airways Co. (NASDAQ:JBLU – Free Report) by 14,595.7% during the 4th quarter, according...
Cerity Partners LLC Sells 2,052 Shares of Watsco, Inc. (NYSE:WSO)
Cerity Partners LLC reduced its stake in shares of Watsco, Inc. (NYSE:WSO – Free Report) by 19.3% during the fourth...
Paylocity Holding Co. (NASDAQ:PCTY) Holdings Raised by Fmr LLC
Fmr LLC increased its position in shares of Paylocity Holding Co. (NASDAQ:PCTY – Free Report) by 138.5% during the 4th...